NCT04423887

Brief Summary

Despite the past decade being dedicated to bone and joint disease, the incidence and prevalence rates of osteoarthritis continues to rise, and till date not curative treatment has been identified for the management of knee osteoarthritis. In terms of conservative management of knee osteoarthritis, pharmacological management has been the mainstay of treatment, however is associated with numerous adverse effects with prolonged use, and it is important to look into the non-pharmacological alternates for the management of knee osteoarthritis. Research has shown resistance exercise training to be the most effective non-pharmacological treatment option for the management of knee osteoarthritis, and the purpose of the current study is to determine if the addition of a non-pharmacological dietry supplement like creatine can amplify the beneficial effects of resistance exercise training in patients with knee osteoarthritis.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
24

participants targeted

Target at below P25 for not_applicable knee-osteoarthritis

Timeline
Completed

Started Jun 2020

Shorter than P25 for not_applicable knee-osteoarthritis

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 5, 2020

Completed
4 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
1 day until next milestone

Study Start

First participant enrolled

June 10, 2020

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 6, 2020

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 6, 2020

Completed
Last Updated

December 9, 2020

Status Verified

December 1, 2020

Enrollment Period

6 months

First QC Date

June 5, 2020

Last Update Submit

December 7, 2020

Conditions

Outcome Measures

Primary Outcomes (10)

  • Knee Pain: Visual Analogue Scale

    Visual Analogue Scale was used to measure pain scoring from 0-10 cm on a horizontal 10cm line. A greater score reflects higher pain intensity.

    2 weeks

  • Knee Pain: Visual Analogue Scale

    Visual Analogue Scale was used to measure pain scoring from 0-10 cm on a horizontal 10cm line. A greater score reflects higher pain intensity.

    4 weeks

  • Knee Range of Motion

    Knee Range of Motion will be quantified by using Gonimeter

    2 weeks

  • Knee Range of Motion

    Knee Range of Motion will be quantified by using Gonimeter

    4 weeks

  • Knee Isometric Muscle Strength

    Knee Isometric Muscle Strength will be quantified by using Modified Sphygmomanometer Dynamometer

    2 weeks

  • Knee Isometric Muscle Strength

    Knee Isometric Muscle Strength will be quantified by using Modified Sphygmomanometer Dynamometer

    4 weeks

  • Six Minute Walk Test

    Six Minute Walk Test will be used to quantify walking related performance fatigability, walking distance and walking speed.

    2 weeks

  • Six Minute Walk Test

    Six Minute Walk Test will be used to quantify walking related performance fatigability, walking distance and walking speed.

    4 weeks

  • 5 repetition sit to stand test

    Time will be measured to perform 5 repetitions of sit to stand activity. Lesser time means a better score.

    2 weeks

  • 5 repetition sit to stand test

    Time will be measured to perform 5 repetitions of sit to stand activity. Lesser time means a better score.

    4 weeks

Secondary Outcomes (6)

  • Knee Injury and Osteoarthritis Outcome Score (KOOS)

    2 weeks

  • Knee Injury and Osteoarthritis Outcome Score (KOOS)

    4 weeks

  • Body Composition

    2 weeks

  • Body Composition

    4 weeks

  • Fall Risk

    2 weeks

  • +1 more secondary outcomes

Study Arms (2)

Control

ACTIVE COMPARATOR
Other: Lower Extremity Resistance Exercise TrainingOther: Home Exercise PlanDevice: Electrotherapy + HeatingProcedure: Joint Mobilization

Creatine Supplementation

EXPERIMENTAL
Other: Lower Extremity Resistance Exercise TrainingOther: Home Exercise PlanDevice: Electrotherapy + HeatingProcedure: Joint MobilizationDietary Supplement: Creatine Supplementation

Interventions

Treadmill walking 5-10 min for warm up Strength training: (80% of 8RM) 3 times supervised exercise for 4 weeks Warm up (Self Paced walking for 10 minutes) leg press, leg extension, Sit to stand squat (mini squats) Stationary Cycling (Maximum Resistance as per patient tolerance till failure) 3 sets 8 reps 10-15 s rep rest interval 1-2 min set rest interval

Also known as: Lower Extremity Strength Training
ControlCreatine Supplementation

2 sets of 10 repetitions/day of AROM isolated knee extension and knee flexion Isometric isolated knee extension and knee flexion Isometric terminal knee extension Sit to stand squat Isometric knee terminal extension

ControlCreatine Supplementation

Interferential Current therapy (2P), in combination with heating pad for 20 minutes

ControlCreatine Supplementation

Tibio-femoral Anterior Glide Tibio-femoral Posterior Glide Patellofemoral Joint Mobilization

Also known as: Manual Therapy
ControlCreatine Supplementation
Creatine SupplementationDIETARY_SUPPLEMENT

Creatine Supplementation 20g/day for 1 week followed by 5 g/day for 3 weeks

Creatine Supplementation

Eligibility Criteria

Age40 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age 40-70 years
  • Knee OA with history not less than three months.
  • Radiological evidences of grade III or less on Kellgren classification.
  • Knee pain on VNRS no more than 8/10

You may not qualify if:

  • Neuromuscular conditions that may lead to fatigue such as multiple Sclerosis
  • Signs of serious pathology (e.g., malignancy, inflammatory disorder, infection).
  • History of trauma or fractures in lower extremity.
  • Signs of lumbar radiculopathy or myelopathy.
  • History of knee surgery or replacement.
  • Patients on intra-articular steroid therapy within two months before the commencement of the study.
  • Impaired skin sensation.
  • Impaired renal function

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Foundation University Institute of Rehabilitation Sciences

Islamabad, Federal, 45710, Pakistan

Location

MeSH Terms

Conditions

Osteoarthritis, Knee

Interventions

Electric Stimulation TherapyMusculoskeletal ManipulationsCreatine

Condition Hierarchy (Ancestors)

OsteoarthritisArthritisJoint DiseasesMusculoskeletal DiseasesRheumatic Diseases

Intervention Hierarchy (Ancestors)

TherapeuticsPhysical Therapy ModalitiesRehabilitationComplementary TherapiesGuanidinesAmidinesOrganic ChemicalsAmino AcidsAmino Acids, Peptides, and Proteins

Study Officials

  • Muhammad Osama, PhD*

    Foundation University Institute of Rehabilitation Sciences

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 5, 2020

First Posted

June 9, 2020

Study Start

June 10, 2020

Primary Completion

December 6, 2020

Study Completion

December 6, 2020

Last Updated

December 9, 2020

Record last verified: 2020-12

Locations